Small hepatocellular carcinoma: MR follow-up of treatment with percutaneous ethanol injection.

Radiology ◽  
1993 ◽  
Vol 187 (1) ◽  
pp. 119-123 ◽  
Author(s):  
S Sironi ◽  
T Livraghi ◽  
E Angeli ◽  
A Vanzulli ◽  
G Villa ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Percutaneous Ethanol Injection ◽  
Small Hepatocellular Carcinoma ◽  
Ethanol Injection

Small hepatocellular carcinoma treated with percutaneous ethanol injection: unenhanced and gadolinium-enhanced MR imaging follow-up.

Radiology ◽  
1994 ◽  
Vol 192 (2) ◽  
pp. 407-412 ◽  
Author(s):  
S Sironi ◽  
F De Cobelli ◽  
T Livraghi ◽  
G Villa ◽  
A Zanello ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Mr Imaging ◽  
Percutaneous Ethanol Injection ◽  
Small Hepatocellular Carcinoma ◽  
Ethanol Injection

scholarly journals Percutaneous ethanol injection (PEI) in the treatment of small hepatocellular carcinoma (HCC)

1996 ◽  
Vol 14 ◽  
pp. 89-94
Author(s):  
Masaaki Ebara ◽  
Hiroyuki Fukuda ◽  
Masaharu Yoshikawa ◽  
Nobuyuki Sugiura ◽  
Hiromitsu Saisho
Keyword(s):  
Hepatocellular Carcinoma ◽  
Percutaneous Ethanol Injection ◽  
Small Hepatocellular Carcinoma ◽  
Ethanol Injection

Palliative Treatment of Hepatocellular Carcinoma with Transcatheter Arterial Embolization

1993 ◽  
Vol 34 (1) ◽  
pp. 26-29 ◽  
Author(s):  
S. Savastano ◽  
G. P. Feltrin ◽  
D. Neri ◽  
P. da Pian ◽  
M. Chiesura-Corona ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Transcatheter Arterial Embolization ◽  
Palliative Treatment ◽  
Arterial Embolization ◽  
Percutaneous Ethanol Injection ◽  
Ethanol Injection ◽  
History Of ◽  
The Mean ◽  
Hcc Recurrence

Thirty-three consecutive patients with previously untreated hepatocellular carcinoma (HCC) and 6 patients with recurrent HCC were treated with transcatheter arterial embolization (TAE). The patients were not eligible for surgical resection or percutaneous ethanol injection. TAE was performed with Lipiodol Ultra-Fluid, epidoxorubicin and Gelfoam, with a mean of 1.7 treatments per patient. CT was performed 15 days after TAE. The mean cumulative survival was 14.2 months in patients with previously untreated HCC. The survival of patients stages Okuda I and II did not differ significantly (p > 0.05); tumor size did not affect survival (p > 0.05). Two patients with recurrent HCC died 7.0 and 9.3 months after the diagnosis of tumor recurrence; the remaining 4 patients are still alive with a maximum follow-up of 22.5 months from the diagnosis of HCC recurrence. Ten complications occurred in 8 patients, and were controlled by medical therapy. Eleven patients died during the study; no death was related to TAE. The series was not randomized, but comparison with the natural history of HCC suggests that TAE is effective as palliative treatment of advanced or recurrent HCC.

Treatment strategy of hepatocellular carcinoma: Comparison between percutaneous ethanol injection and radiofrequency ablation, a three-year follow-up study

2003 ◽  
Vol 124 (4) ◽  
pp. A771
Author(s):  
Stefano Fiorucci ◽  
Eleonora Distrutti ◽  
Olivia Morelli ◽  
Mari Olivia Pensi ◽  
Monia Baldoni ◽  
...  
Keyword(s):  
Hepatocellular Carcinoma ◽  
Radiofrequency Ablation ◽  
Treatment Strategy ◽  
Percutaneous Ethanol Injection ◽  
Ethanol Injection ◽  
Follow Up Study
Sign in / Sign up

Export Citation Format

Share Document